Hematopoietic cell transplantation is the preferred therapy for a substantial proportion of
patients with life-threatening diseases of the lymphohematopoietic system. Recent advances …

The CD34+ cell surface antigen is expressed on progenitor cells required for blood stem cell
transplantation. The number of cells expressing CD34+ can be used to assess the …

The CD34 antigen is expressed by committed and uncommitted hematopoietic progenitor
cells and is increasingly used to assess stem cell content of peripheral blood progenitor cell …

PURPOSE To analyze factors that affect the collection of peripheral-blood stem cells (PBSC)
before transplant and the tempo of engraftment after transplant. PATIENTS AND METHODS …

Peripheral blood stem cells (PBSCs) are widely used in autologous transplantation because
of ease of collection and rapid hematopoietic reconstitution. However, PBSCs have rarely …

There is evidence that the total cellular content of placental cord blood (PCB) grafts is
related to the speed of engraftment, though the total nucleated cell (TNC) dose is not a …

Clinical studies involving patients with myelodysplastic syndromes or multiple myeloma
have shown the efficacy of lenalidomide by reducing and often eliminating malignant cells …

Allogeneic peripheral blood stem cell (PBSC) transplants from HLA-identical siblings were
performed in 37 patients with advanced hematologic malignancies. Outcomes were …

A retrospective analysis of granulocyte colony-stimulating factor (G-CSF)–mobilized
peripheral blood mononuclear cell (G-PBMC) products harvested from healthy donors …

PURPOSE To compare autologous bone marrow (BM) with peripheral-blood progenitor
cells (PBPC) as hematopoietic rescue after high-dose chemotherapy (HDCT). PATIENTS …